Home »
Academic Articles & Research Papers
Showing 11 of 11 academic articles
Wang R, Dodd S, Rook S, Graham S et al. • Implementation science communications
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s43058-026-01068-w
PMC: PMC13737714
Ou Y, Lu W, Zhao H, Demetrious C et al. • iScience
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.isci.2026.118018
PMC: PMC13734790
Wendland EM, Martins RS, Kops NL, Eidt G et al. • NPJ vaccines
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1038/s41541-026-01495-9
PMC: PMC13550542
Griffith BC, Iliassu S, Mbanga C, Ngenge BM et al. • PLOS global public health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1371/journal.pgph.0006349
PMC: PMC13557348
Cândido LM, Armani JPS, Moura LL, Danielewicz AL et al. • Vaccines
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/vaccines14100863
PMC: PMC13709507
Park S, Rosser EN, Zhang L, Wysong MD et al. • PloS one
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1371/journal.pone.0359273
PMC: PMC13704837
Ngozi Osueke, Sunny Udeze, Olayinka Ogundoyin, Michael Eze et al. • Discover Social Science and Health
(2025)
Abstract Non-vaccination against human papillomavirus (HPV) has serious implications on population health. This study therefore investigates the awareness and knowledge of HPV and its vaccines, attitude towards HPV vaccines, and adoption ra...
DOAJ
Open Access (DOAJ)
DOI: 10.1007/s44155-025-00243-z
Sara Badre-Esfahani, Lone Kjeld Petersen, Camilla Rahr Tatari, Jan Blaakær et al. • PLoS ONE
(2021)
BackgroundCervical cancer screening (CCS) and human papillomavirus vaccination (HPVV) are effective measures against cervical cancer (CC). Attendance in HPVV and CCS provides the greatest protection, while combined non-attendance in HPVV an...
DOAJ
Open Access (DOAJ)
DOI: 10.1371/journal.pone.0250816
Renata Malheiro, César Magalhães, Cláudia Camila Dias, Acácio Gonçalves Rodrigues et al. • Vaccines
(2024)
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection among young women. Notably, more than ten years after the introduction of HPV vaccination programs in Europe, it is essential to review the real-world evidence ...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/vaccines12050548
Wosene Berhanu, Simon Yigremachew, Claudia Hanson, Helena Avermark et al. • Global Health Action
(2026)
Background Cervical cancer causes morbidity and mortality among women worldwide, particularly in low- and middle-income countries (LMICs). Human Papillomavirus (HPV) vaccine is crucial for cervical cancer prevention, yet the vaccination rat...
DOAJ
Open Access (DOAJ)
DOI: 10.1080/16549716.2026.2635822
Sahil Khan Warsi, Siff Malue Nielsen, Barbara A. K. Franklin, Shukhrat Abdullaev et al. • Vaccines
(2023)
Human papillomavirus (HPV) vaccines effectively prevent cervical cancer, most of which results from undetected long-term HPV infection. HPV vaccine introduction is particularly sensitive and complicated given widespread misinformation and v...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/vaccines11040754